DiNuzzo Private Wealth
TGTX icon

DiNuzzo Private Wealth’s TG Therapeutics TGTX Stock Holding History

DiNuzzo Private Wealth’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279 Buy
+5
New +$271 ﹤0.01% 1220
2025
Q1 		– Sell
-8
Closed -$241 – 1419
2024
Q4 		$241 Buy
+8
New +$230 ﹤0.01% 1252

Other funds holding TGTX

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

DiNuzzo Private Wealth's TGTX Position: Q3 2026 in Review

DiNuzzo Private Wealth opened a new position in TG Therapeutics (TGTX) in Q3 2026: 5 shares worth $279. The stake represents ﹤0.01% of the portfolio and ranks #1220 among its holdings. This is a return to the name: DiNuzzo Private Wealth previously reported a position in TGTX as recently as Q4 2024.

DiNuzzo Private Wealth first reported a position in TGTX in Q4 2024 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • DiNuzzo Private Wealth held 5 shares of TG Therapeutics worth $279 as of Q3 2026.
  • TG Therapeutics was a new DiNuzzo Private Wealth position in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1220 holding.
  • DiNuzzo Private Wealth first reported a position in TG Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.